Bovine mastitis is usually caused by either Gram positive or Gram negative bacteria, reducing the quantity and quality of milk produced. This investigation using capillary electrophoresis and mass spectroscopy, studied peptides in milk from cows with clinical mastitis in comparison to milk from healthy cows to identify biomarkers for mastitis. In addition, the milk peptidome from udders infected with Gram positive Staphylococcus aureus (S. aureus) or with Gram negative Escherichia coli (E. coli), was examined to assess differential diagnosis between the causative agent. Comparison of the peptidome between healthy (n = 10) and mastitic milk (n = 27) identified 154 peptides for a biomarker panel which in a model for diagnosis of mastitis showed 100% sensitivity and specificity. β-casein and α s1 casein provided the majority of peptides identified in this model. The peptidome comparison of milk from mastitis cases caused by S. aureus (n = 8) or E. coli (n = 11) revealed a biomarker panel of 47 peptides which discriminated between cause of infection with a sensitivity of 75% and a specificity of 100%. β-casein fragments were the most common of the peptides in this model.
Introduction
Mastitis is an inflammatory disease of the mammary gland parenchyma which is characterized by a range of physical and chemical changes of milk and pathological changes in the udder tissues [1, 2] . Significant milk changes that can be observed in bovine mastitis are the presence of clots in milk, milk discolouration and high levels of leukocyte numbers in affected milk which lead to a rise in somatic cell count (SCC). Furthermore, clinical signs occur in bovine mastitis including swelling, heat and pain in the udder. Mastitis is usually caused by bacterial infection with major pathogens being Streptococcus agalactiae, Staphylococcus aureus (S. aureus) and Mycoplasma bovis as well as environmental pathogens, including Streptococcus species (Streptococcus uberis and Streptococcus dysgalactiae) and environmental coliforms Gram negative bacteria Escherichia coli (E. coli), Klebsiella spp., Citrobacter spp., Enterobacter spp., Enterobacter faecalis and Enterobacter faecium, and other Gram negative bacteria such as Serratia, Pseudomonas and Proteus [1, 3, 4] . Mastitis is one of the most prevalent diseases in dairy cows. It is an endemic disease and is the most frequent and most costly disease affecting dairy herds worldwide [5] [6] [7] . It affects the quality of the milk through changes in milk composition and has marked economic consequences for the dairy industry. The economic losses due to mastitis can be caused by milk production losses, use of treatments, discarded milk, veterinary services, labour, product quality, materials and investments, diagnostics, other diseases and culling [5] . Persistent decrease in milk production is the main detrimental effect that contributes to the economic impact of mastitis [8] and can be caused by both clinical and subclinical mastitis. While identification of clinical mastitis can be achieved by identification of the clinical signs described above, subclinical mastitis where these signs are not evident is a more problematic diagnostic task. Currently subclinical mastitis is identified by measurement of SCC in milk [9] which required submission of sample to a laboratory for automated cell counting or associated measures such as conductivity or lactate dehydrogenase activity. The California Mastitis test which is a measure of SCC by agglutination may also be applied on farm [7] . Identification of alternative biomarkers of mastitis which could be adapted to rapid, on-farm diagnostic systems would be a valuable tool for early detection and treatment of mastitis.
Changes are known to take place in the milk proteome during mastitis. Clinical mastitis causes decreases in caseins, α-lactalbumin and β-lactoglobulin [10] and increases in serum albumin and serotransferrin. Further studies have identified additional proteins with altered expression in milk from dairy cows with experimental induction of mastitis [11] [12] [13] . These studies have revealed increased concentrations of chaperonins, DNA-binding proteins, enzymes, transport proteins and structural proteins, complement factors C3 and C4, lactoferrin, transferrin, apolipoprotein AI, fibrinogen, glycosylation-dependent cell adhesion molecule-1, peptidoglycan recognition receptor protein and cyclic dodecapeptide-1.
In addition proteins secreted from neutrophils and lymphocytes have been identified.
An investigation by Ibeagha-Awemu et al. [14] has suggested that different pathogens have varied effects on the milk proteome. Thus, in natural cases of the disease, the proteome of whey from cows with mastitis caused by E. coli and S. aureus differed substantially in comparison to whey from healthy cows as revealed by one-dimensional, liquid chromatography tandem MS (LC-MS/MS). A total of 73 proteins were found to be significantly different between normal whey and whey from quarters infected with either E. coli or S. aureus. Infection with E. coli caused a greater change in the expression of the proteins.
A potential cause of alteration of the milk proteome in mastitis is proteolysis of milk protein by bacterial or endogenous proteases. Following induction of mastitis by infusion of lipoteichoic acid (LTA), the toxin of S. aureus, Larsen et al. [15] identified, by 2-D gel electrophoresis, hydrolysis of β-and α S1 -caseins 6 h after infusion with the toxin. Examination of the peptides at this and later time points, using reversedphase HPLC and MALDI-TOF MS/MS, detected increases in the milk peptidome with several different peptides being characterized and found to originate from α S1 -and β-caseins.
The analysis of change in the peptide content of biological fluid such as serum or urine is increasingly being used as a means to discover biomarkers for the diagnosis and monitoring of disease. There have been a number of studies, especially using urine, that have developed biomarkers models for a number of different diseases using capillary electrophoresis (CE) and mass spectrometry (MS). Those investigated so far range from renal disorders [16, 17] to cardiovascular disease [18] and diabetes [19] . Many of these biomarker profiles have been recorded in a database made up from over 13,000 samples [20] . These biomarkers are not based on a single analyte but are composed of a group or panel of proteins/peptides. Changes in the profile or pattern can indicate a trend toward or away from the disease state.
It is likely that changing patterns of the peptides of milk could provide a source of biomarkers for mastitis so that application of advanced peptide biomarker detection and analysis could be a valuable addition tool in the diagnosis of mastitis.
The aim of this investigation was to undertake a study of the peptides present in milk from healthy dairy cows in comparison to milk from cows with naturally occurring clinical mastitis to determine if peptide biomarkers in milk could be identified for use in disease diagnosis. A second aim was to determine if peptide biomarkers could be identified which could distinguish between the bacteria causing naturally occurring cases of mastitis by analysis of samples in which either E. coli or S. aureus had been identified as the pathogenic agent as a means for differential diagnosis between bacterial cause [4] .
2.
Material & methods 
Sample preparation
Milk samples were defrosted at room temperature prior to centrifugation at 16,000 ×g for 10 min at 4°C to remove the milk fat. An aliquot of 700 μl of centrifuged milk was added to 700 μl of 2 M urea, 100 mM NaCl, 10 mM NH 4 OH containing 0.02% SDS, as described by Albalat et al. [21] . To remove higher molecular mass proteins the sample was ultrafiltered using Centrisart, Sartorius (Geottingen, Germany) ultracentrifugation filter devices (20 kDa MW) at 2000 g until 1. 
Protein estimation
Protein concentration in milk extracted samples was checked using the BCA assay Uptima from Interchim (Montluçon, France). A known amount (25 μl) of each standard and milk extracted samples was pipetted into microplate wells in duplicate. The BCA assay reagent was then added (200 μl) and mixed. The sample mixtures were incubated at 37°C for 30 min. Prior to reading the results at the optical absorbance of 562 nm, the microplate was allowed to cool to room temperature. The standard curve of protein concentration, bovine serum albumin (Sigma Aldrich, Dorset, UK) ranging from 2 up to 500 μg/ml was plotted and the protein concentration in the sample was interpolated. Freeze-dried aliquots were resuspended in appropriate volume of Milli Q water to reach a concentration of 2 μg/μl before running in the CE.
CE-MS analysis
Samples were re-suspended in HPLC-grade H 2 O shortly before CE-MS analyses, as described [21] . CE-MS analysis was performed using a P/ACE MDQ capillary electrophoresis system (Beckman Coulter, Fullerton, USA) using a 90 cm 360 μm OD, 50 μm ID capillary with a tapered tip (New Objective, Woburn, USA) on-line coupled to a micrOTOF MS (Bruker Daltonic, Bremen, Germany) as described previously [22] . The ESI sprayer (Agilent Technologies, Palo Alto, CA, USA) was grounded, and the ion spray interface potential was set between −4 and −4.5 kV. Data acquisition and MS acquisition methods were automatically controlled by the CE via contact-close-relays. Spectra were accumulated every 3 s, over a range of m/z 350 to 3000. Accuracy, precision, selectivity, sensitivity, reproducibility, and stability of the CE-MS measurements were demonstrated elsewhere [16] .
LC-MS/MS analysis
The milk extracts were also analysed on a Dionex Ultimate 3000 RSLS nano-flow system (Dionex, Camberly UK). The samples (5 μl) were loaded onto a Dionex 100 μm × 2 cm 5 μm C18 nano-trap column at a flowrate of 5 μl/min by an Ultimate 3000 RS autosampler (Dionex, Camberley UK). The composition of the loading solution was 0.1% formic acid and acetonitrile (98:2). Once loaded onto the trap column the sample was then washed off into an Acclaim PepMap C18 nano-column 75 μm × 15 cm, 2 μm 100 Å at a flowrate of 0.3 μl/min. The trap and nano-flow column were maintained at 35°C in a column oven in the Ultimate 3000 RSLC. The samples were eluted with a gradient of solvent A: 0.1% formic acid and acetonitrile (98:2) versus solvent B: 0.1% formic acid and acetonitrile (20:80) starting at 5% B rising to 50% B over 100 min. The column was washed using 90% B before being equilibrated prior to the next sample being loaded. The eluant from the column was directed to a Proxeon nano-spray ESI source (Thermo Fisher Hemel UK) operating in positive ion mode then into an Orbitrap Velos FTMS. The ionisation voltage was 2.5 kV and the capillary temperature was 200°C. The mass spectrometer was operated in MS-MS mode scanning from 380 to 2000 amu. The top 20 multiply charged ions were selected from each full scan for MS-MS analysis, the fragmentation method was CID at 35% collision energy. The ions were selected for MS 2 using a data dependant method with a repeat count of 1 and repeat and exclusion time of 15 s. Precursor ions with a charge state of 1 were rejected. The resolution of ions in MS 1 was 60,000 and 7500 for HCD MS 2 .
CE-MS data processing
Mass spectra were processed using MosaiquesVisu software (Mosaiques Diagnostics, Hannover, Germany), including peak picking, deconvolution and deisotoping [23] . The software automatically examines all mass spectra from a CE-MS analysis for signals above the threshold (SNR^4). Only signals that are present in 3 consecutive spectra are accepted. Next, the isotopic distribution is assessed and charge is assigned based on the isotopic distribution, using a matched filtering algorithm. This operation results in a list wherein all signals that could be interpreted are defined by mass/charge, charge, migration time, and signal intensity (ion counts). This list is transformed into a dataset containing only mass, migration time, and signal intensity, signals that represent the same compound but with a different charge state are combined. The final result is a list of the compounds present in the sample with their identity defined by mass, migration time and their relative abundance defined by ion counts.
CE migration time and ion signal intensity were normalized to allow compilation and comparison of samples. Reference signals of over 380 'milk housekeeping polypeptides' were used for CE-time calibration by local regression. The same peptides were used for ion signal intensity normalization by a applying a global linear regression. The resulting peak list contained the molecular mass (Da) and normalized CE migration time (min) for each feature. Normalized signal intensity can be used as a measure of relative abundance. Data sets were accepted only if they passed a strict quality control criteria: A minimum of 950 chromatographic features (mean number of features minus one standard deviation) must be detected with a minimal MS resolution of 8000 (required resolution to resolve ion signals with z = 6) in a minimal migration time interval (the time window, in which separated signals can be detected) of 10 min. After calibration, the mean deviation of migration time (compared to reference standards) must be below 0.35 min.
Control and disease-specific polypeptide patterns were generated using support vector machine (SVM)-based MosaCluster software Mosaiques Diagnostics (Hannover, Germany).
LC-MS/MS-data processing
Raw spectral data from LC-MS/MS analysis of the samples were uploaded to Thermo Proteome Discoverer 1.2 Thermo Scientific (Hemel Hempstead, UK). Peak picking was performed under default settings for FTMS analysis such that only peptides with signal to noise ratio higher than 1.5 and belonging to precursor peptides between 700-8000 Da were considered. Peptide and protein identification was performed with SEQUEST algorithm. An in house compiled database containing proteins from the latest version of the UniProt SwissProt database was compiled to include only Bos taurus, E. coli and S. aureus entries. This concatenated database was selected to facilitate peptide identification and reduce the probability for false positive identifications upon making searches against 3 differently sized FASTA databases. No enzyme cleavage was selected and oxidation of methionine and proline was chosen as variable modifications. Precursor tolerance was set at 20 ppm and 0.1 Da for MS/MS fragment ions. Resulting peptides and protein hits were further screened by excluding peptides with an error tolerance higher than 10 ppm and by accepting only those hits listed as high confidence by Proteome Discoverer software. Theoretical migration times in CE-MS for any resulting peptides were calculated so that sequences obtained with LC-MS/MS could be subsequently assigned to a position in the CE-MS analysis.
Results

Polypeptide fingerprinting for control and infected groups
In each sample analysed we were able to detect > 1000 different peptides based on migration time and mass. The molecular weight range of these peptides ranged from 0.8 to 20 kDa. Data from individual CE-MS analysis was compiled according to their group in order to develop biomarker patterns for the different conditions studied.
Healthy versus mastitis samples
Initially in this work we investigated whether differences existed in the milk proteome of healthy cows (n = 10) when compared to mastitic cows, regardless of their bacterial cause (n = 27). The polypeptide fingerprints of these two groups were very different as shown in Fig. 1 , with many of the multiply charged high molecular weight peptides being absent from the infected group. A total of 508 peptides were significantly different after correcting for multiple testing (BH < 0.05). Fig. 1 -Compiled CE-MS peptide fingerprints of the control milk samples (n = 10) (A) and all mastitic milk samples (n = 27) (B). On the X axis the CE migration time (min) is plotted against the molecular mass (kDa) on the Y axis on a logarithmic scale. The Z axis represents the mean signal intensity.
Model generation of the polypeptide fingerprints
Based on the data described above, multiple testing of statistical analysis was done to discriminate peaks between control and infected groups. In the first model, using a training set of randomly selected controls (n = 5) and infected (n = 14) samples we selected discriminatory peptides with a BH < 0.05 and with the area under curve (AUC) set at 1. Following these very stringent conditions a group of 154 of the 508 peaks was determined to be a potential biomarker panel that can be used to discriminate between control and infected groups. Upon using leave-one-out cross-validation of the training set for verification an accuracy of 100% was observed. This model was applied to a test set of controls (n = 5) and infected (n = 13) with a sensitivity and specificity of 100%. Therefore, peptides from this model could be used to discriminate between non-infected and infected group with an accuracy of 100% (Fig. 2) .
E. coli infected versus S. aureus infected samples
The next step was to investigate the differences in milk proteome of infected samples caused by the two different bacterial pathogens (E. coli versus S. aureus). The polypeptide profiles of these 2 different groups did not differ as markedly as is demonstrated in Fig. 3 . A total of 47 peptides were significantly different between both groups after correcting for multiple testing (BH < 0.05). In this case the biomarker panel was made up of all 47 discriminatory peptides.
Model generation of the polypeptide fingerprints
Based on the polypeptide fingerprints described above, multiple testing of statistical analysis was done to discriminate peaks between two infected groups caused by E. coli and S. aureus. A model was generated using a training set of un-selected samples from E. coli (n = 11) and S. aureus (n = 8) and a group of 47 peptides (significantly different peptides after correcting for multiple testing) was determined to be a biomarker panel that could discriminate between causative bacteria. Upon cross-validation of the training set an accuracy of 100% was obtained. This model was then tested in a test set of E. coli (n = 4) and S. aureus (n = 4). This model allowed a correct classification of 4/4 E. coli and 3/4 S. aureus thus giving a sensitivity on the limited test set of 75% while the specificity was 100% (Fig. 4). 
Peptide sequencing
In order to identify the discriminatory peptides of the models by their sequences, samples were analysed using LC-MS/MS. The data was then compared with that of the UniProt SwissProt database which was compiled to include only Bos taurus, E. coli and S. aureus entries. All identified peptides obtained with high confidence from the LC-MS/MS analysis, that matched the mass and migration time of a peptide in the CE-MS analysis used in the models, are listed in Tables 1 and 2 . In the model classifying healthy versus infected samples 33 peptides were identified out of 154 peptides (Table 1) . On the other hand, from the model used to classify samples from E. coli versus S. aureus 15 peptides were sequenced out of the 47 that formed the model ( Table 2 ). The frequency of occurrence of each peptide is listed in Tables 1 and 2 as well as their mean amplitude.
Protein identification
As described above, the protein identity was derived from matching the amino acid sequences against a protein database. The identified and named proteins are presented as in Tables 1  and 2 . Combining both sets, peptides originating from twelve proteins were identified with the majority of the originating proteins being known milk protein such as α S1 -casein and β-casein.
Discussion
The chosen peptidomic method of capillary electrophoresis (CE) coupled with the electrospray mass spectrometry is known for its rapid (approximately 45 min per sample), sensitive and automated approach [24] . The principle of separation in a CE system ensures that all peptides present in the sample will migrate through the capillary and pass into the detector in a consistent solvent suitable for detection. This analytical platform was used to detect quantitative differences in the peptidome of milk between samples of milk from healthy cows (control) and milk from infected udder quarters of cows with mastitis caused by two different bacterial pathogens (E. coli and S. aureus).
All milk samples were analysed by CE-MS and only polypeptides present at a frequency > 80% in at least one group (control or cases) were chosen for analysis. The milk polypeptide patterns of infected cows were markedly different from control cows. The milk polypeptide patterns when comparing the causative bacteria (E. coli and S. aureus) were more similar but still had identifiable quantifiable differences.
There are only a very small number of studies in which peptide analysis has been performed on bovine milk samples during mastitis [15, 25] . Both studies employed the same method, RP-HPLC, in separating the peptides, while further protein characterization was performed by MALDI-TOF/MS/ MS. These studies focused on the result of proteolysis caused by different types of proteolytic enzymes. Wedholm et al. [25] successfully identified 10 peptides from milk with high SCC (16 000 000 cells/ml). Larsen et al. [15] identified approximately 20 different peptides in milk samples from mammary glands infused with LTA from S. aureus, with peptides resulting from the action of endogenous proteases in response to the LTA. The objective of these studies was to investigate milk protease activity during mastitis. In contrast, the objective of the present study was to determine how the peptide profile of milk samples is altered in bovine mastitis. The CE-MS methodology used in this study allows quantitative analysis of all the peptides present in the samples. It has a number of advantages in peptide analysis over the more popular methodology of LC separation followed by MS or MS/MS identification [26] .
A secondary objective was to discover and characterize the peptides that made up the biomarker in bovine mastitis. However, due to the small sample loading capacity in CE it is not possible to obtain MS/MS data to allow sequencing. Sequencing was carried out using LC-MS/MS. LC separation of peptides misses many of the most polar peptides and also the larger more hydrophilic molecules and therefore many of the peptides used to generate the biomarker panels have no sequence data. However, we did see some overlap with the 14 peptide sequences described by Larsen et al. [15] . In Table 1 we have no exact matches though peptide IDs 2367, 2719, 3223 and 3879 are smaller fragments of one of the peptides listed by Larsen et al. [15] . In Table 2 there is one exact match with another peptide described by Larsen, peptide ID 10468 and a smaller fragment of this peptide ID 9569. As the majority of peptides in the biomarkers are only seen in CE-MS and our sequencing is by LC-MS/MS it is reassuring that there is some overlap with the LC fractions identified by MALDI/MS/MS analysis of Larsen et al. [15] . From the results it is clear that in clinical mastitis the milk proteome, or more precisely the milk peptidome as only peptides of <20 kDa were examined in this study, increases in complexity with an increase in the number and intensity of low MW peptides. The high sensitivity and specificity of the differentiation of milk from healthy animals compared to that from udder quarters suffering from mastitis were an encouraging result in biomarker discovery for this economically important disease. Furthermore the potential for discrimination between the causative bacteria by peptide analysis is an exciting development. Currently, such discrimination would require time consuming bacterial identification. If a rapid method could be developed, following validation of discrimination in future studies, there could be Fig. 4 -Box-and-whisker plots of the classification factor obtained for the E. coli (n = 11) vs. S. aureus (n = 8) of the training set and the test set in a blinded assessment of infected milk samples from E. coli (n = 4) and S. aureus (n = 4) samples.
major benefits in targeting treatment to the correct pathogen. Whether the differences in peptidome pattern are due directly to bacterial action in breaking down larger milk proteins or are due to differences in the host response to infection is not clear but should be the objective of future investigation.
A total of 48 polypeptides were sequenced by LC-MS/MS (Tables 1 & 2) . These polypeptides were identified based on their protein accession information and amino acid sequences and were found to be fragments of larger and mostly known milk proteins. The UniPortKB database was used to search for each of the protein identities. The result of the database search using the peptide sequence produced a list of proteins including α S1 -casein, β-casein, β-lactoglobin, lactoperoxidase, osteopontin, interleukin 4-receptor, fibroblast growth factor binding protein, glycosylation-dependent cell adhesion molecule 1 (GlyCAM-1), rho guanine nucleotide exchange factor, signal transducer and activator of transcription 1 and tubulin α-1C chain. One peptide produced two possible sequences which matched both mass and migration time from the CE-MS data. The proteins identified from these two potential sequences were β-casein and ANKRD9 protein. As we are interested in discriminatory polypeptides, the discussion will focus on the polypeptides and related proteins that were used to discriminate between control, infected and two different bacterial pathogen groups.
Statistically, peptides derived from β-lactoglobin, α S1-casein, β-casein, lactoperoxidase, osteopontin, interleukin 4 receptor, FGFBP and glyCAM 1 were the peptides that can be used to discriminate the control from the infected groups.
During mastitis, the endogenous proteolytic activity in milk increases substantially [15, 27, 28] and it is known that plasmin can hydrolyse β-casein, α S2 -casein and α S1 -casein [29] which explains the presence of peptides from α S1 -casein and β-casein in milk from the infected group. The results presented here, from investigation of naturally occurring mastitis, are in agreement with investigations of experimental induction of mastitis with LTA [15] or lipopolysaccharide [28] in which plasmin activity in milk increased and casein derived peptides were identified by reverse phase HPLC [15] or 2 dimension electrophoresis and mass spectroscopy [28] during mastitis. It is likely that plasmin and other endogenous peptides are responsible in part at least for the production of the peptides identified by this investigation. As α S1 -casein and β-casein are major milk proteins [30, 31] they constitute a principle substrate for milk proteolysis resulting from the action of endogenous proteinases such as plasmin [32] . Although proteolytic activity in milk is known to increase as a result of mastitis, other factors such as the stage of lactation and lactation number can also contribute to increase in this proteolytic activity [33] . The presence of GlyCAM 1 protein in bovine milk has been reported previously [11, 34] . Smolenski et al. [11] have identified it as one of the minor milk protein that is present in all peak lactation, colostrums, mastitic whey and the milk fat globule membrane (MFGM) whilst Boehmer et al. [34] considered it to be a host defence protein. It was surprising to observe this minor milk protein which acts in the host defence mechanism to appear in the control group in higher frequency compared with the infected group.
The fibroblast growth factor-binding protein (FGFBP) is a secreted carrier protein that releases fibroblast growth factors (FGFs) from the extracellular matrix storage and thus enhancing the FGF activity [35] . Kawakami et al. [36] concluded that FGFBP may be tightly associated with lactoferrin in bovine milk. Plath et al. [37] have successfully examined the expression and localization of FGFBP in the bovine mammary gland and it may be important in the local regulation of the bovine mammary gland.
Statistically, peptides from α S1 -casein, β-casein and tubulin α-1C chain protein were the peptides that can be used to discriminate between the bacterial cause of the mastitis.
β-casein derived peptides were assigned to discriminate S. aureus from E. coli infected group. As discussed above, the presence of mastitis can increase the proteolytic activity in bovine milk and it was not surprising that these polypeptides were the result from β-casein hydrolysis, but it is not clear how a number of β-casein derived peptides can contribute to differential identification of the bacterial cause while other β-casein peptides are included in the group to differentiate milk from mastitic from healthy udders. It was also not clear if β-casein peptides alone can be applied to discriminate S. aureus from E. coli infected milk samples.
Although several proteins were successfully identified using the protein database based on their sequences, those proteins cannot be used per se as potential markers for each group. This study only sequenced peptides resulting from specific fragments of proteins. The peptide identity provides an insight into which milk proteins were subjected to proteolysis or played a role in the disease mechanism. It is apparent that specific peptides resulting from particular proteases of the host or bacteria were of varying importance in contributing to the discriminatory algorithms. However, no ultimate conclusion can be made based on the protein identity that has been identified in each of the group as the group sizes are relatively small. Further study of more extensive numbers of samples, stage of disease (clinical and subclinical) and causative bacteria is warranted to determine if these promising results are indicative of a viable approach to improve the diagnosis of bovine mastitis. Eventual use of the panel of peptide found here in differential diagnosis of mastitis could have a significant impact on the health of dairy cows and in control of this important disease [3] allowing more efficient targeting of antibiotic use. It would also be interesting to investigate the time-course of infection and determine the earliest time that can be applied to diagnose an infected cow based on the proposed polypeptide biomarker of bovine mastitis. More information on peptide sequencing will also lead to a better understanding of the pathophysiology of bovine mastitis. 
